Zymvol Biomodeling
Seed Round in 2025
Zymvol accelerates the discovery & development of new industrial enzymes through computer simulations.
Zymvol Biomodeling
Seed Round in 2023
Zymvol accelerates the discovery & development of new industrial enzymes through computer simulations.
Sim&Cure, SA is a French company that specializes in developing software solutions aimed at enhancing endovascular and aneurysm treatment planning. Founded in 2014 and based in Grabels, the company focuses on optimizing medical devices through patient-specific simulations. Its flagship product, Sim&Size, assists clinicians in determining the optimal size of cerebral medical devices tailored to individual patients' anatomies. Additionally, Sim&Cure offers modules such as StentDeviceSizing (STsize), which simulates the deployment of laser-cut stents, and FlowDiverterSize (FDsize), which aids in selecting the appropriate positioning and sizing for treating cerebral aneurysms. By providing crucial information on device deformation post-deployment, Sim&Cure supports medical device manufacturers and neurologists in delivering effective treatments for neurovascular disorders.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.